Cystathionine beta synthase
| Cystathionine beta synthase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||
| EC number | 4.2.1.22 | ||||||||
| CAS number | 9026-88-4 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| Gene Ontology | AmiGO / QuickGO | ||||||||
| |||||||||
Cystathionine beta synthase (CBS) is an enzyme that plays a crucial role in the metabolism of the amino acid homocysteine. It catalyzes the first step of the transsulfuration pathway, converting homocysteine to cystathionine. This reaction is pyridoxal phosphate (PLP)-dependent and involves the condensation of homocysteine with serine.
Function[edit | edit source]
CBS is a key enzyme in the methionine cycle, which is essential for the regulation of homocysteine levels in the body. Elevated levels of homocysteine, a condition known as hyperhomocysteinemia, are associated with an increased risk of cardiovascular disease, stroke, and other health issues. By converting homocysteine to cystathionine, CBS helps to maintain homocysteine at safe levels.
Structure[edit | edit source]
CBS is a homotetramer, meaning it consists of four identical subunits. Each subunit contains a PLP-binding domain, which is essential for its enzymatic activity. The enzyme also has a heme-binding domain, which is thought to play a regulatory role.
Genetic Aspects[edit | edit source]
The gene encoding CBS is located on chromosome 21 in humans. Mutations in the CBS gene can lead to homocystinuria, a rare genetic disorder characterized by high levels of homocysteine in the blood and urine. This condition can result in a variety of symptoms, including developmental delay, osteoporosis, and thromboembolism.
Clinical Significance[edit | edit source]
Deficiencies in CBS activity can lead to elevated homocysteine levels, which are a risk factor for several diseases. Homocystinuria is the most well-known condition associated with CBS deficiency. Treatment often involves dietary management and supplementation with vitamin B6, vitamin B12, and folate to help reduce homocysteine levels.
Research[edit | edit source]
Ongoing research is focused on understanding the detailed mechanisms of CBS function and regulation, as well as developing new treatments for conditions associated with CBS deficiency. Studies are also exploring the broader implications of homocysteine metabolism in health and disease.
See also[edit | edit source]
References[edit | edit source]
 | This enzyme-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
